(Q41360776)

29 September 2017

Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect (English)

1 reference

29 September 2017

Li CY

1

1 reference

29 September 2017

Suardet L

series ordinal

2

1 reference

29 September 2017

Little JB

series ordinal

3

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 March 1995

1 reference

Journal of Biological Chemistry

29 September 2017

1 reference

29 September 2017

270

1 reference

29 September 2017

4971-4974

1 reference

29 September 2017

10

1 reference

TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights

29 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

Transforming growth factor-beta: recent progress and new challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

Identification of G1 kinase activity for cdk6, a novel cyclin D partner

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

A cell cycle regulator potentially involved in genesis of many tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

p53 mutations in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.10.4971

21 January 2018

Identifiers

DOI

10.1074/JBC.270.10.4971

1 reference

29 September 2017

1 reference